Ascentage Pharma Group International

HK$29.28As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6855Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR (2.41%)
Div yield —
ROE (236.63%)
Biotechnology
Beta (5Y) 0.77
PE TTM —
TSR TTM (55.97%)
Mkt cap HK$10.77B
ROIC (34.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$36
22.27%
(30.71%)
Hold 10|8|11|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.66
0.67
0.70
0.66
11.34%
13.85%
24.26%
7.21%
Revenue¥M
536.8
521.0
543.3
539.8
7.10%
3.55%
11.30%
5.87%
Peers (US$1.373B)
Cap (US$)
PE
1.093B
12.92x
1.375B
198.4x
Capital
TTM
5Y
10Y
Leveragex
1.875
(1.012)
(0.998)
EBIT/Intx
0.337
1.418
1.140
Own earn%
(67.42)
(167.29)
(132.50)
Sh yield%
33.84
37.40
32.58
Owners
Insiders/Inst%
5.47
67.64
Short interest%
2.99
SBC / revenue%
2.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
24–27
$1 testx
—
Incr. ROIC%
2